Premium
Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines
Author(s) -
Su Nan,
Pan YuanXiang,
Zhou Mi,
Harvey Richard C.,
Hunger Stephen P.,
Kilberg Michael S.
Publication year - 2008
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.21213
Subject(s) - asparagine synthetase , asparaginase , cell culture , medicine , messenger rna , asparagine , cancer research , cell , leukemia , enzyme , microbiology and biotechnology , immunology , lymphoblastic leukemia , biology , biochemistry , gene , genetics
Background Asparaginase (ASNase) is an essential component of most treatment protocols for childhood acute lymphoblastic leukemia (ALL). Although increased asparagine synthetase (ASNS) expression may contribute to ASNase resistance, there is conflicting data from patient samples with regard to correlation between ASNS mRNA content and ASNase sensitivity. Procedure Both T‐cell and B‐cell derived ALL cell lines were treated with ASNase and then monitored for cell proliferation, cell death, and ASNS mRNA and protein expression. Results Despite elevated ASNS mRNA following ASNase treatment, different ALL cell lines varied widely in translation to ASNS protein. Although ASNS mRNA levels did not consistently reflect ASNase sensitivity, there was an inverse correlation between ASNS protein and ASNase‐induced cell death. Expression of ASNS in an ASNase‐sensitive cell line resulted in enhanced ASNase resistance, and conversely, siRNA‐mediated inhibition of ASNS expression promoted increased drug sensitivity. Conclusions These observations provide an explanation for the ASNase sensitivity of ALL cells and demonstrate the importance of measuring ASNS protein rather than mRNA in predicting ASNase responsiveness. Pediatr Blood Cancer 2008;50:274–279. © 2007 Wiley‐Liss, Inc.